ArticleCancer2012

Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study.

Martee L Hensley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.